In-Person Access Only | 7.75 CE/CME Credits

The 9th Annual West Oncology Conference served as a valuable forum for presenting and discussing new research findings in oncology education.

Learners were provided updates on practice-changing data in breast cancers, genitourinary cancers, hematological malignancies, gastrointestinal cancers, and lung cancers – all in a practical and interactive format, fostering discussion and impacting patient clinical outcomes. This accredited meeting was an in-person conference with on-demand access for registered attendees.

Conference Agenda

8:00 AM
Coffee and Exhibits

8:30 AM
Program Chair Welcome

8:35 AM
Lifestyle Tips and Strategies
Sami Mansfield, BA, ACSM-CET | Cancer Wellness for Life

8:40 AM
Updates from ASCO GI
Axel Grothey, MD | West Cancer Center

9:00 AM
Management of Colorectal Liver Metastases
Sepideh Gholami, MD, MAS, FACS, FSSO | Feinstein Institutes for Medical Research

9:20 AM
Panel Discussion and Q&A - Gastrointestinal Cancer
Axel Grothey, MD | West Cancer Center
Heather Greene, MSN, FNP, AOCNP | West Cancer Center
Evan Glazer, MD, PhD, FACS, FSSO | The University of Tennessee Health Science Center
Noam Vanderwalde, MD, MS | West Cancer Center
David Shibata, MD, FACS, FSSO, FASCRS | The University of Tennessee Health Science Center

9:35 AM
Adjuvant vs Neoadjuvant Therapy and Sequencing in Lung Cancer
Jason Porter, MD | West Cancer Center 

10:10 AM
Panel Discussion and Q&A - Lung Cancer
Jason Porter, MD | West Cancer Center
Jane Y. Zhao, MD, MS | The University of Tennessee Health Science Center
Raymond Osarogiagbon, MD | Baptist Cancer Center
Holger Gieschen, MD | West Cancer Center

10:20 AM
Break and Exhibits

10:35 AM
Non-CME Breakfast - Pfizer - Clinical Case Reviews: Treatment of a Broad Range of Patients With HR+/HER2- Metastatic Breast Cancer

11:20 AM
Update on Cellular Therapy in Lymphoma
Brion Randolph, MD | The University of Tennessee Health Science Center

11:40 AM
Sarcoma
David Portnoy, MD, FACP | West Cancer Center

12:00 PM
Multiple Myeloma
Jason Chandler, MD | West Cancer Center 

12:20 PM
Panel Discussion and Q&A - Hematological Malignancies
Jason Chandler, MD | West Cancer Center 
Mihaela Onciu, MD | West Cancer Center
Brion Randolph, MD | The University of Tennessee Health Science Center
Holger Gieschen, MD | West Cancer Center

12:35 AM
Lifestyle Tips and Strategies
Sami Mansfield, BA, ACSM-CET | Cancer Wellness for Life

1:40 PM
Housekeeping and Survey

1:45 PM
Molecular Tumor Board Panel
Axel Grothey, MD | West Cancer Center
Lee Schwartzberg, MD, FACP | Renown Health

2:25 AM
Survivorship and Sexual Health
Amy Siston, PhD | The University of Chicago

2:45 AM
West Cancer Center - The Unicorn of Cancer Centers
Lee Schwartzberg, MD | Renown Health

3:05 PM
Networking Reception

4:05 PM
Adjourn

Adgenda Subject To Change. All times are CST.

• Learning Objectives

  • Determine best application of new targeted therapies in patients with early stage and metastatic disease

  • Discuss the advances in systemic therapy likely to change current practices for treatment of breast cancer

  • Know how to utilize genomic tools for systemic therapy decision making and prediction of treatment response.

  • Be familiar with germ-line genetic testing options for hereditary breast cancer, including advantages and disadvantages of extended panel testing

  • Evaluate local therapy options for operable breast cancer depending on stage, and the use of neoadjuvant therapy

  • Identify evidence-based recommendations for decreasing symptoms and improving quantity and/or quality of life in survivors

• Accreditation Information | 7.75

  In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

  • Nurses (ANCC) Credit Designation
    Amedco LLC designates this activity for a maximum of 7.75 ANCC contact hours.

  • Physicians (ACCME) Credit Designation
    Amedco LLC designates this live activity for a maximum of 7.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
    Amedco LLC designates this activity for a maximum of 7.75 knowledge-based CPE contact hours.
    
    NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.

• What to Expect | In-Person Learners

  • Free registration for all healthcare providers

  • Expert sessions that present the most clinically relevant data, research, and clinical strategies

  • Enduring video content for watching at your leisure

  • Real-time discussion and debate

  • Networking with peers, colleagues, and medical professionals

  • Access to the latest industry information and resources

  • Catered meals through-out the program